Market Segmentation:
- By Product Type
- Consumables
- Instruments
- Services
- By Technology
- Immunoassays
- Clinical Chemistry
- Sensors
- Molecular Diagnostics
- Others (Radioimmunoassays, Electrochemiluminescence)
- By Disease Indication
- Hypothyroidism
- Hyperthyroidism
- Thyroid Cancer
- Others (Goiter, Thyroiditis)
- By End-User
- Hospitals
- Diagnostic Laboratories
- Academic and Research Institutes
- Others (Ambulatory Surgical Centers, Clinics)
- By Analyte
- Thyroid-Stimulating Hormone (TSH)
- Thyroxine (T4)
- Triiodothyronine (T3)
- Thyroglobulin
- Thyroid Antibodies
- Others (Calcitonin, Thyroid-Binding Globulin)
- By Sample Type
- Serum
- Plasma
- Others (Dried Blood Spots, Urine)
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
The current market size of the Thyroid Function Testing industry is USD 1.8 billion.
Rising prevalence of thyroid disorders, increasing aging population, adoption of advanced diagnostic technologies, growing awareness about early detection, increasing healthcare expenditure, and favorable reimbursement policies.
High costs of advanced tests, lack of skilled professionals, stringent regulatory requirements, reimbursement issues, and limited awareness in developing regions.
The leading component segment in the Thyroid Function Testing Market is the consumables segment (assay kits, reagents, etc.), which is used for conducting thyroid tests.
Which are the major players operating in the Thyroid Function Testing Market? Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific Inc., Beckman Coulter, Inc., bioMérieux SA, DiaSorin S.p.A., Ortho Clinical Diagnostics, and Sysmex Corporation.
The North America region is expected to lead the Thyroid Function Testing Market, with a projected CAGR of 8.7% and a market size of USD 1.3 billion by 2031.
Rising prevalence of thyroid disorders, increasing aging population, adoption of advanced diagnostic technologies, growing awareness about early detection, increasing healthcare expenditure, and favorable reimbursement policies.